Skip to main content

Table 4 Analysis of correlations between CSF-GPNMB and other parameters in study cohort 2

From: Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease

Correlations

CSF GPNMB

 

Total sample

PET

PET+

Age

0.5155 (0.0009)

0.5872 (0.0051)

0.4280 (0.0866)

CSF total Tau

0.3001 (0.0671)

0.4714 (0.0310)

0.0147 (0.9585)

CSF pTau181

0.4217 (0.0084)

0.7206 (0.0002)

0.0189 (0.9454)

CSF Aβ38

0.4168 (0.0092)

0.4935 (0.0230)

0.4461 (0.0744)

CSF Aβ40

0.4071 (0.0112)

0.5971 (0.0043)

0.2144 (0.4086)

CSF Aβ42

0.1581 (0.3431)

0.3831 (0.0865)

0.1642 (0.5276)

CSF ratio Aβ42/40

−0.1238 (0.4591)

−0.0273 (0.9066)

−0.0392 (0.8835)

  1. Pearson’s rho (p-value)
  2. Spearman’s rho (p-value)
  3. CSF cerebrospinal fluid